2023 Q2 Form 10-Q Financial Statement

#000147604523000047 Filed on May 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $84.48M $67.61M
YoY Change 3.32% 23.19%
Cost Of Revenue $17.48M $40.48M
YoY Change -57.73% 20.17%
Gross Profit $67.00M $27.14M
YoY Change 65.77% 27.99%
Gross Profit Margin 79.31% 40.13%
Selling, General & Admin $36.89M $34.34M
YoY Change 5.55% 17.55%
% of Gross Profit 55.06% 126.53%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $14.62M $14.26M
YoY Change -4.32% -5.17%
% of Gross Profit 21.82% 52.54%
Operating Expenses $51.56M $48.59M
YoY Change 2.66% 9.83%
Operating Profit $15.44M $2.067M
YoY Change -5.04% -162.45%
Interest Expense -$6.253M $6.438M
YoY Change -190.15% 0.77%
% of Operating Profit -40.51% 311.47%
Other Income/Expense, Net
YoY Change
Pretax Income $9.365M -$5.042M
YoY Change 0.46% -48.02%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings $7.157M -$4.849M
YoY Change -21.79% -48.67%
Net Earnings / Revenue 8.47% -7.17%
Basic Earnings Per Share $0.15 -$0.14
Diluted Earnings Per Share $0.15 -$0.14
COMMON SHARES
Basic Shares Outstanding 48.86M shares 48.85M shares
Diluted Shares Outstanding 48.96M shares 48.84M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $32.90M $22.47M
YoY Change 85.35% 23.83%
Cash & Equivalents $32.90M $22.47M
Short-Term Investments
Other Short-Term Assets $9.604M $9.632M
YoY Change 16.14% 1.07%
Inventory
Prepaid Expenses
Receivables $5.705M $4.547M
Other Receivables $0.00 $0.00
Total Short-Term Assets $48.21M $36.65M
YoY Change 44.79% 17.07%
LONG-TERM ASSETS
Property, Plant & Equipment $1.269B $1.277B
YoY Change -2.88% -8.35%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $14.80M $13.28M
YoY Change 47.43% 60.04%
Other Assets $4.965M $4.805M
YoY Change 20.48% 3.42%
Total Long-Term Assets $1.288B $1.295B
YoY Change -2.42% -7.91%
TOTAL ASSETS
Total Short-Term Assets $48.21M $36.65M
Total Long-Term Assets $1.288B $1.295B
Total Assets $1.337B $1.332B
YoY Change -1.26% -7.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $29.96M $26.62M
YoY Change 7.35% 11.63%
Accrued Expenses $21.02M $21.95M
YoY Change -6.21% -2.66%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $56.31M $53.85M
YoY Change 8.33% 12.07%
LONG-TERM LIABILITIES
Long-Term Debt $465.9M $468.7M
YoY Change -4.75% -19.94%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $465.9M $468.7M
YoY Change -4.75% -19.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $56.31M $53.85M
Total Long-Term Liabilities $465.9M $468.7M
Total Liabilities $548.2M $522.6M
YoY Change 1.32% -17.51%
SHAREHOLDERS EQUITY
Retained Earnings -$259.2M -$262.9M
YoY Change 1.49% 0.15%
Common Stock $1.048B $1.048B
YoY Change 0.01% 0.01%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $788.5M $784.7M
YoY Change
Total Liabilities & Shareholders Equity $1.337B $1.332B
YoY Change -1.26% -7.36%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $7.157M -$4.849M
YoY Change -21.79% -48.67%
Depreciation, Depletion And Amortization $14.62M $14.26M
YoY Change -4.32% -5.17%
Cash From Operating Activities $27.99M $4.751M
YoY Change 8.12% -213.8%
INVESTING ACTIVITIES
Capital Expenditures $7.500M $8.100M
YoY Change -225.73% -121.26%
Acquisitions $0.00
YoY Change -100.0%
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$7.500M -$8.100M
YoY Change -110.13% -78.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -8.541M -$6.054M
YoY Change -91.33% -115.59%
NET CHANGE
Cash From Operating Activities 27.99M $4.751M
Cash From Investing Activities -7.500M -$8.100M
Cash From Financing Activities -8.541M -$6.054M
Net Change In Cash 11.95M -$9.403M
YoY Change 789.72% 174.62%
FREE CASH FLOW
Cash From Operating Activities $27.99M $4.751M
Capital Expenditures $7.500M $8.100M
Free Cash Flow $20.49M -$3.349M
YoY Change -35.67% -109.87%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001476045
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-34693
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
CHATHAM LODGING TRUST
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-1200777
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
222 Lakeview Avenue, Suite 200
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
West Palm Beach
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33401
CY2023Q1 dei City Area Code
CityAreaCode
561
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
802-4477
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 cldt Accrued Share Based Compensation
AccruedShareBasedCompensation
135000 usd
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
48855795 shares
CY2023Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1258002000 usd
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1264252000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22473000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
26274000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
13277000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
18879000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19120000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19297000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
353000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
344000 usd
CY2023Q1 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
4547000 usd
CY2022Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
5178000 usd
CY2023Q1 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
4805000 usd
CY2022Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
6428000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
9632000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
3430000 usd
CY2023Q1 us-gaap Assets
Assets
1331856000 usd
CY2022Q4 us-gaap Assets
Assets
1343738000 usd
CY2023Q1 us-gaap Loans Payable
LoansPayable
394406000 usd
CY2022Q4 us-gaap Loans Payable
LoansPayable
430553000 usd
CY2023Q1 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
0 usd
CY2023Q1 us-gaap Construction Loan
ConstructionLoan
0 usd
CY2022Q4 us-gaap Construction Loan
ConstructionLoan
39331000 usd
CY2023Q1 us-gaap Unsecured Debt
UnsecuredDebt
74341000 usd
CY2022Q4 us-gaap Unsecured Debt
UnsecuredDebt
0 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
26616000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
28528000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
21953000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
22108000 usd
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
5284000 usd
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
5221000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
522600000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
525741000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
4800000 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
4800000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
4800000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
4800000 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
48000 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
48000 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48855155 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48855155 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48808105 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
48808105 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
488000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
488000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1047095000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1047023000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-262921000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-252665000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
784710000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
794894000 usd
CY2023Q1 us-gaap Minority Interest In Operating Partnerships
MinorityInterestInOperatingPartnerships
24546000 usd
CY2022Q4 us-gaap Minority Interest In Operating Partnerships
MinorityInterestInOperatingPartnerships
23103000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
809256000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
817997000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1331856000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1343738000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
67614000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
54885000 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
40478000 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
33683000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14258000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
15036000 usd
CY2023Q1 us-gaap Real Estate Taxes And Insurance
RealEstateTaxesAndInsurance
6105000 usd
CY2022Q1 us-gaap Real Estate Taxes And Insurance
RealEstateTaxesAndInsurance
4958000 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4341000 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3942000 usd
CY2023Q1 cldt Acquisition Related Costs And Other Charges
AcquisitionRelatedCostsAndOtherCharges
0 usd
CY2022Q1 cldt Acquisition Related Costs And Other Charges
AcquisitionRelatedCostsAndOtherCharges
250000 usd
CY2023Q1 cldt Reimbursable Costs From Related Parties
ReimbursableCostsFromRelatedParties
365000 usd
CY2022Q1 cldt Reimbursable Costs From Related Parties
ReimbursableCostsFromRelatedParties
326000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
65547000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
58195000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
2067000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-3310000 usd
CY2023Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
20000 usd
CY2022Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
0 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
6438000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
6389000 usd
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-691000 usd
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5042000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9699000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-5042000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-9699000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-193000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-253000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4849000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-9446000 usd
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1987000 usd
CY2022Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1987000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6836000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11433000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48838742 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48787519 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48838742 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48787519 shares
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
814193000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
487000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1159000 usd
CY2022Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1987000 usd
CY2022Q1 cldt Noncontrolling Interest Increase Decrease From Reallocation
NoncontrollingInterestIncreaseDecreaseFromReallocation
0 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-9699000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
804139000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
817997000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1334000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
3420000 usd
CY2023Q1 cldt Regular Distributions On Long Term Investment Plan
RegularDistributionsOnLongTermInvestmentPlan
0.07
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
181000 usd
CY2023Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1987000 usd
CY2023Q1 cldt Noncontrolling Interest Increase Decrease From Reallocation
NoncontrollingInterestIncreaseDecreaseFromReallocation
0 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-5042000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
809256000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-5042000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
-9699000 usd
CY2023Q1 us-gaap Depreciation
Depreciation
14204000 usd
CY2022Q1 us-gaap Depreciation
Depreciation
14970000 usd
CY2023Q1 cldt Amortization Of Deferred Franchise Fees
AmortizationOfDeferredFranchiseFees
59000 usd
CY2022Q1 cldt Amortization Of Deferred Franchise Fees
AmortizationOfDeferredFranchiseFees
66000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
304000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
358000 usd
CY2023Q1 cldt Gain Loss On Extinguishment Of Debt Noncash
GainLossOnExtinguishmentOfDebtNoncash
-667000 usd
CY2022Q1 cldt Gain Loss On Extinguishment Of Debt Noncash
GainLossOnExtinguishmentOfDebtNoncash
0 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1452000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1294000 usd
CY2023Q1 cldt Increase Decrease In Right Of Use Asset
IncreaseDecreaseInRightOfUseAsset
-177000 usd
CY2022Q1 cldt Increase Decrease In Right Of Use Asset
IncreaseDecreaseInRightOfUseAsset
-169000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
-631000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
625000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
0 usd
CY2022Q1 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
206000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6208000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6740000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1338000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3620000 usd
CY2023Q1 cldt Increase Decrease In Lease Liability
IncreaseDecreaseInLeaseLiability
-155000 usd
CY2022Q1 cldt Increase Decrease In Lease Liability
IncreaseDecreaseInLeaseLiability
-142000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
4751000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4175000 usd
CY2023Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
8100000 usd
CY2022Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
4131000 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
31013000 usd
CY2023Q1 cldt Payments To Acquire Investment In Hotel Properties Under Development
PaymentsToAcquireInvestmentInHotelPropertiesUnderDevelopment
0 usd
CY2022Q1 cldt Payments To Acquire Investment In Hotel Properties Under Development
PaymentsToAcquireInvestmentInHotelPropertiesUnderDevelopment
2947000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8100000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-38091000 usd
CY2023Q1 us-gaap Proceeds From Secured Lines Of Credit
ProceedsFromSecuredLinesOfCredit
0 usd
CY2022Q1 us-gaap Proceeds From Secured Lines Of Credit
ProceedsFromSecuredLinesOfCredit
40000000 usd
CY2023Q1 us-gaap Proceeds From Construction Loans Payable
ProceedsFromConstructionLoansPayable
0 usd
CY2022Q1 us-gaap Proceeds From Construction Loans Payable
ProceedsFromConstructionLoansPayable
3443000 usd
CY2023Q1 us-gaap Repayments Of Construction Loans Payable
RepaymentsOfConstructionLoansPayable
39331000 usd
CY2022Q1 us-gaap Repayments Of Construction Loans Payable
RepaymentsOfConstructionLoansPayable
0 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
75000000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
0 usd
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
36213000 usd
CY2022Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2280000 usd
CY2023Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 usd
CY2022Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
173000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
14000 usd
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
3538000 usd
CY2022Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
147000 usd
CY2023Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
1987000 usd
CY2022Q1 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
1987000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-6054000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
38842000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9403000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3424000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
45153000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
29869000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35750000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
26445000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
6030000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
6355000 usd
CY2023Q1 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
0 usd
CY2022Q1 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
330000 usd
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
7000 usd
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
53000 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Employee Benefit Plan
StockIssuedDuringPeriodSharesEmployeeBenefitPlan
43378 shares
CY2022Q1 us-gaap Stock Issued During Period Shares Employee Benefit Plan
StockIssuedDuringPeriodSharesEmployeeBenefitPlan
34672 shares
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
5284000 usd
CY2022Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
1656000 usd
CY2023Q1 cldt Accrued Share Based Compensation
AccruedShareBasedCompensation
118000 usd
CY2023Q1 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
1332000 usd
CY2022Q1 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
1095000 usd
CY2023Q1 cldt Aggregate Number Of Rooms In Hotels
AggregateNumberOfRoomsInHotels
5914 room
CY2023Q1 cldt Number Of States In Which Hotels Are Owned
NumberOfStatesInWhichHotelsAreOwned
16 state
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the balance sheet date and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</span></div>
CY2022Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
1666707000 usd
CY2023Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
416621000 usd
CY2022 cldt Business Combination Property Acquisition Costs Capitalized
BusinessCombinationPropertyAcquisitionCostsCapitalized
48000 usd
CY2022Q2 cldt Number Of Hotels Sold
NumberOfHotelsSold
3 hotel
CY2023Q1 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
400000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
300000 usd
CY2022Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
402455000 usd
CY2023Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1258002000 usd
CY2023Q1 us-gaap Land
Land
289597000 usd
CY2022Q4 us-gaap Land
Land
289589000 usd
CY2023Q1 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
1267561000 usd
CY2022Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
1267035000 usd
CY2023Q1 cldt Furniture Fixtures And Equipment
FurnitureFixturesAndEquipment
98669000 usd
CY2022Q4 cldt Furniture Fixtures And Equipment
FurnitureFixturesAndEquipment
98373000 usd
CY2023Q1 us-gaap Development In Process
DevelopmentInProcess
18796000 usd
CY2022Q4 us-gaap Development In Process
DevelopmentInProcess
11710000 usd
CY2023Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
1674623000 usd
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
4800000 shares
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
1264252000 usd
CY2023Q1 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
489426000 usd
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
469714000 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
470257000 usd
CY2023Q1 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
967000 usd
CY2022Q4 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
373000 usd
CY2023Q1 us-gaap Secured Debt
SecuredDebt
468747000 usd
CY2022Q4 us-gaap Secured Debt
SecuredDebt
469884000 usd
CY2023Q1 cldt Number Of Mortgage Debt Lenders Enforcing Cash Trap Provisions
NumberOfMortgageDebtLendersEnforcingCashTrapProvisions
4 mortgage_debt_lender
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
5100000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
81750000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
297003000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
90961000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0 usd
CY2023Q1 cldt Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
0 usd
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
469714000 usd
CY2023Q1 us-gaap Deferred Finance Costs Gross
DeferredFinanceCostsGross
967000 usd
CY2023Q1 us-gaap Secured Debt
SecuredDebt
468747000 usd
CY2023Q1 us-gaap Interest Rate Fair Value Hedge Derivative At Fair Value Net
InterestRateFairValueHedgeDerivativeAtFairValueNet
0 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q1 cldt Common Stock Total Regular Dividends Per Share Declared
CommonStockTotalRegularDividendsPerShareDeclared
0.07
CY2023Q1 cldt Regular Distributions On Long Term Investment Plan
RegularDistributionsOnLongTermInvestmentPlan
0.07
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2023Q1 cldt Regular Distributions On Long Term Investment Plan
RegularDistributionsOnLongTermInvestmentPlan
0.07
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2023Q1 cldt Regular Distributions On Long Term Investment Plan
RegularDistributionsOnLongTermInvestmentPlan
0.07
CY2023Q1 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
0.41406
CY2023Q1 us-gaap Preferred Stock Dividends Per Share Declared
PreferredStockDividendsPerShareDeclared
0.41406
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 cldt Common Stock Number Of Votes Per Common Share
CommonStockNumberOfVotesPerCommonShare
1 vote
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48855155 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
4800000 shares
CY2023Q1 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2000000 usd
CY2023Q1 cldt Stockholders Equity Note Stock Redemption Exchange Ratio
StockholdersEquityNoteStockRedemptionExchangeRatio
1
CY2023Q1 cldt Vested Operating Partnership Units Held By Current And Former Employees
VestedOperatingPartnershipUnitsHeldByCurrentAndFormerEmployees
1587317000 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
128812 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
196898 shares
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6836000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11433000 usd
CY2023Q1 cldt Dividends Paid On Unvested Restricted Shares
DividendsPaidOnUnvestedRestrictedShares
28000 usd
CY2022Q1 cldt Dividends Paid On Unvested Restricted Shares
DividendsPaidOnUnvestedRestrictedShares
0 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-6864000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-11433000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48838742 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48787519 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48838742 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48787519 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2186000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1894000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1272000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1571000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2115000 usd
CY2023Q1 cldt Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
63555000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
72593000 usd
CY2023Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
50640000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
21953000 usd
CY2023Q1 cldt Operating Lease Fixed Lease Payments
OperatingLeaseFixedLeasePayments
300000 usd
CY2023Q1 us-gaap Variable Lease Payment
VariableLeasePayment
200000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19297000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
22108000 usd
CY2023Q1 cldt Amortization Of Right Of Use Asset
AmortizationOfRightOfUseAsset
177000 usd
CY2023Q1 cldt Amortization Of Lease Liability
AmortizationOfLeaseLiability
155000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19120000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
21953000 usd
CY2022Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
400000 usd
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P40Y8M1D
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0664
CY2023Q1 cldt Management Fees Recorded Within Hotel Other Operating Expenses
ManagementFeesRecordedWithinHotelOtherOperatingExpenses
2300000 usd
CY2022Q1 cldt Management Fees Recorded Within Hotel Other Operating Expenses
ManagementFeesRecordedWithinHotelOtherOperatingExpenses
1900000 usd
CY2023Q1 cldt Management Fees Recorded Within Hotel Other Operating Expenses
ManagementFeesRecordedWithinHotelOtherOperatingExpenses
2300000 usd
CY2022Q1 cldt Management Fees Recorded Within Hotel Other Operating Expenses
ManagementFeesRecordedWithinHotelOtherOperatingExpenses
1900000 usd
CY2023Q1 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
200000 usd

Files In Submission

Name View Source Status
0001476045-23-000047-index-headers.html Edgar Link pending
0001476045-23-000047-index.html Edgar Link pending
0001476045-23-000047.txt Edgar Link pending
0001476045-23-000047-xbrl.zip Edgar Link pending
cldt-20230331.htm Edgar Link pending
cldt-20230331.xsd Edgar Link pending
cldtex31120230331.htm Edgar Link pending
cldtex31220230331.htm Edgar Link pending
cldtex32120230331.htm Edgar Link pending
cldtex3220230331.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
cldt-20230331_def.xml Edgar Link unprocessable
cldt-20230331_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cldt-20230331_cal.xml Edgar Link unprocessable
cldt-20230331_pre.xml Edgar Link unprocessable
cldt-20230331_htm.xml Edgar Link completed
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending